This article discusses a study that surveyed patients with inflammatory bowel diseases like Crohn's disease and ulcerative colitis about their use of cannabis. The researchers hypothesized that cannabis works as an anti-inflammatory through receptors called endocannabinoids. The survey found that in most cases, patients reported cannabis helped relieve abdominal pain, diarrhea and reduced appetite. While cannabis has side effects, it improved quality of life for these patients and could be a viable treatment option.

1. Third annotated bibliography: Lal S, Prasad N, Ryan M, Tangri S, Silverberg M,
Gordon A, Steinhart H. 2011. Cannabis use amongst patients with inflammatory bowel
disease. European Journal of Gastroenterology &Hepatology 23(10): 891-896
This article has a direct connection with my review paper because it discusses
exactly what I want to discuss. It researches the possibility of the use of cannabis as an
anti-inflammatory for bowel diseases. The researchers express that a good hypothesis to
why the cannabis works as an anti-inflammatory Is because of the existence of
endocannabinoids (receptors for the cannabis). A survey was conducted among patients,
all eighteen years or older and no sex preference, with Crohn’s disease and ulcerative
colitis, which are both inflammatory bowel diseases.. Certain factors, such as
demographics, psychosocial factors, disease and therapy history, quality of life and
current or previous use of cannabis, were taking into consideration . In the majority of the
cases (use statistics), the use of cannabis helped relieve abdominal pain, diarrhea and
reduced appetite. The use of cannabis, like any other drug, does have side effects.
However, it improves the life of the patients with these diseases, making it a good option
for them.